VBI.H — Vivione Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsMicro Cap
Annual cashflow statement for Vivione Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | 2017 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.82 | -3.4 | 1.4 | -0.085 | -0.132 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 1.16 | 0.531 | -3.08 | -0.074 | 0.008 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.794 | -0.009 | 0.53 | 0.052 | 0.12 |
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.36 | -2.82 | -1.09 | -0.107 | -0.004 |
| Capital Expenditures | -0.031 | -0.192 | -0.09 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.099 | 0 | 0.308 | 0 | — |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0.068 | -0.192 | 0.218 | 0 | — |
| Financing Cash Flow Items | 1.21 | -0.086 | 0.516 | 0.002 | 0.007 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.61 | 0.123 | 0.553 | 0.002 | 0.007 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.32 | -2.89 | -0.323 | -0.105 | 0.003 |